Kimia Farma Revenue vs. Current Valuation
| KAEF Stock | IDR 645.00 15.00 2.38% |
For Kimia Farma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Kimia Farma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Kimia Farma Persero utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Kimia Farma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Kimia Farma Persero over time as well as its relative position and ranking within its peers.
Kimia |
Kimia Farma Persero Current Valuation vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Kimia Farma's current stock value. Our valuation model uses many indicators to compare Kimia Farma value to that of its competitors to determine the firm's financial worth. Kimia Farma Persero is considered the number one company in revenue category among its peers. It is rated fifth overall in current valuation category among its peers reporting about 1.14 of Current Valuation per Revenue. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kimia Farma's earnings, one of the primary drivers of an investment's value.Kimia Revenue vs. Competition
Kimia Farma Persero is considered the number one company in revenue category among its peers. Market size based on revenue of Health Care industry is now estimated at about 124.34 Trillion. Kimia Farma retains roughly 12.86 Trillion in revenue claiming about 10% of equities under Health Care industry.
Kimia Current Valuation vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Kimia Farma |
| = | 12.86 T |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Kimia Farma |
| = | 14.62 T |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Kimia Current Valuation vs Competition
Kimia Farma Persero is rated fifth overall in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 230.46 Trillion. Kimia Farma holds roughly 14.62 Trillion in current valuation claiming about 6% of equities under Health Care industry.
Kimia Farma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Kimia Farma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Kimia Farma will eventually generate negative long term returns. The profitability progress is the general direction of Kimia Farma's change in net profit over the period of time. It can combine multiple indicators of Kimia Farma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
PT Kimia Farma Tbk produces and sells medicines, herbal medicines, iodine, salts, quinine and their derivative products, and vegetable oils in Indonesia, rest of Asia, Europe, Australia, Africa, and New Zealand. The company was founded in 1817 and is headquartered in Jakarta, Indonesia. Kimia Farma operates under Drug ManufacturersSpecialty Generic classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 11772 people.
Kimia Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Kimia Farma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Kimia Farma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Kimia Farma's important profitability drivers and their relationship over time.
Use Kimia Farma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kimia Farma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kimia Farma will appreciate offsetting losses from the drop in the long position's value.Kimia Farma Pair Trading
Kimia Farma Persero Pair Trading Analysis
The ability to find closely correlated positions to Kimia Farma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kimia Farma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kimia Farma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kimia Farma Persero to buy it.
The correlation of Kimia Farma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kimia Farma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kimia Farma Persero moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kimia Farma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Kimia Farma position
In addition to having Kimia Farma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Gold and Gold Mining Thematic Idea Now
Gold and Gold Mining
Large and mid-size companies, ETFs and funds that are either investing, exploring or producing, gold or indirectly involved in trading or making gold products. The Gold and Gold Mining theme has 100 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Gold and Gold Mining Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Kimia Stock
To fully project Kimia Farma's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Kimia Farma Persero at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Kimia Farma's income statement, its balance sheet, and the statement of cash flows.